These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31258978)

  • 41. 3D pharmacophoric similarity improves multi adverse drug event identification in pharmacovigilance.
    Vilar S; Tatonetti NP; Hripcsak G
    Sci Rep; 2015 Mar; 5():8809. PubMed ID: 25744369
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
    Pearson RK; Hauben M; Goldsmith DI; Gould AL; Madigan D; O'Hara DJ; Reisinger SJ; Hochberg AM
    Int J Med Inform; 2009 Dec; 78(12):e97-e103. PubMed ID: 19230751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection.
    Pacurariu AC; Straus SM; Trifirò G; Schuemie MJ; Gini R; Herings R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Arlett P; van der Lei J; Sturkenboom MC; Coloma PM
    Drug Saf; 2015 Dec; 38(12):1201-10. PubMed ID: 26370104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
    Subeesh V; Maheswari E; Singh H; Beulah TE; Swaroop AM
    Curr Drug Saf; 2019; 14(1):21-26. PubMed ID: 30362421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system database.
    Gandhi PK; Gentry WM; Bottorff MB
    Pharmacotherapy; 2012 Oct; 32(10):902-9. PubMed ID: 23033229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Signal Detection of Adverse Events Following Pneumococcal Vaccines from the Korea Adverse Event Reporting System Database, 2005-2016.
    Kim KS; Oh IS; Kim HJ; Song I; Park MS; Shin JY
    Yonsei Med J; 2020 Mar; 61(3):243-250. PubMed ID: 32102125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project.
    Patadia VK; Coloma P; Schuemie MJ; Herings R; Gini R; Mazzaglia G; Picelli G; Fornari C; Pedersen L; van der Lei J; Sturkenboom M; Trifirò G;
    Expert Rev Clin Pharmacol; 2015 Jan; 8(1):95-102. PubMed ID: 25487079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reference set for performance testing of pediatric vaccine safety signal detection methods and systems.
    Brauchli Pernus Y; Nan C; Verstraeten T; Pedenko M; Osokogu OU; Weibel D; Sturkenboom M; Bonhoeffer J;
    Vaccine; 2016 Dec; 34(51):6626-6633. PubMed ID: 26496461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Feasibility of including green tea products for an analytically verified dietary supplement database.
    Saldanha L; Dwyer J; Andrews K; Betz J; Harnly J; Pehrsson P; Rimmer C; Savarala S
    J Food Sci; 2015 Apr; 80(4):H883-8. PubMed ID: 25817236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progress in development of an integrated dietary supplement ingredient database at the NIH Office of Dietary Supplements.
    Dwyer JT; Picciano MF; Betz JM; Fisher KD; Saldanha LG; Yetley EA; Coates PM; Radimer K; Bindewald B; Sharpless KE; Holden J; Andrews K; Zhao C; Harnly J; Wolf WR; Perry CR
    J Food Compost Anal; 2006 Aug; 19():S108-S114. PubMed ID: 25309034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Prevalence of Dietary Supplement Use Among Elementary, Junior High, and High School Students: A Nationwide Survey in Japan.
    Kobayashi E; Nishijima C; Sato Y; Umegaki K; Chiba T
    Nutrients; 2018 Aug; 10(9):. PubMed ID: 30154316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adverse Events Due to Insomnia Drugs Reported in a Regulatory Database and Online Patient Reviews: Comparative Study.
    Borchert JS; Wang B; Ramzanali M; Stein AB; Malaiyandi LM; Dineley KE
    J Med Internet Res; 2019 Nov; 21(11):e13371. PubMed ID: 31702558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. iDISK: the integrated DIetary Supplements Knowledge base.
    Rizvi RF; Vasilakes J; Adam TJ; Melton GB; Bishop JR; Bian J; Tao C; Zhang R
    J Am Med Inform Assoc; 2020 Apr; 27(4):539-548. PubMed ID: 32068839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Analysis of Spontaneously Reported Adverse Events].
    Nakamura M
    Yakugaku Zasshi; 2016; 136(4):549-56. PubMed ID: 27040337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An Alternative to Disproportionality: A Frequency-Based Method for Pharmacovigilance Data Mining.
    Jokinen JD; Lievano F; Scarazzini L; Truffa M
    Ther Innov Regul Sci; 2018 May; 52(3):294-299. PubMed ID: 29714535
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ADEpedia-on-OHDSI: A next generation pharmacovigilance signal detection platform using the OHDSI common data model.
    Yu Y; Ruddy KJ; Hong N; Tsuji S; Wen A; Shah ND; Jiang G
    J Biomed Inform; 2019 Mar; 91():103119. PubMed ID: 30738946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generalized enrichment analysis improves the detection of adverse drug events from the biomedical literature.
    Winnenburg R; Shah NH
    BMC Bioinformatics; 2016 Jun; 17():250. PubMed ID: 27333889
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dietary supplement product composed of natural ingredients as a suspected cause of erythema multiforme: A case report and identification for the confident false positivity of lymphocyte transformation test.
    Utsunomiya N; Oyama N; Chino T; Utsunomiya A; Hida Y; Hasegawa M
    J Dermatol; 2019 Mar; 46(3):234-239. PubMed ID: 30623481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
    Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.